Announcements and Circulars
-
- 03 Jul 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
-
- 18 Jun 2025
- Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON WEDNESDAY, 18 JUNE 2025
-
- 03 Jun 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
-
- 07 May 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
-
- 22 Apr 2025
- Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period] NOTICE OF ANNUAL GENERAL MEETING
-
- 22 Apr 2025
- Proxy Forms FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 18, 2025
-
- 22 Apr 2025
- Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval] PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING
-
- 03 Apr 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
-
- 26 Mar 2025
- Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
-
- 13 Mar 2025
- Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
-
- 04 Mar 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
-
- 05 Feb 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
-
- 06 Jan 2025
- Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
-
- 02 Jan 2025
- Announcements and Notices - [Inside Information] INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE DRUG REGULATORY AUTHORITY OF PAKISTAN ON THE REGISTRATION OF OUR CORE PRODUCT, CMAB008 (INFLIXIMAB FOR INJECTION)